Lundbeck gives up on Alzheimer's drug, rival to Axovant pill
Wednesday, February 8, 2017 - 08:51
in Health & Medicine
(Reuters) - Two remaining late-stage clinical trials testing an experimental Alzheimer's drug from Denmark's Lundbeck have failed, scuppering hopes for the medicine and underscoring the difficulty of developing such treatments.